You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Rapamune

Showing 1 - 25 of 287
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Severe Aplastic Anemia Trial run by the National Heart, Lung, and Blood Institute (NHLBI) (Sirolimus)

Recruiting
  • Severe Aplastic Anemia
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 27, 2023

Muscle Atrophy, Age-Related Sarcopenia Trial in Derby (Rapamune (sirolimus) 1Mg Tablet, Unilateral resistance exercise training)

Recruiting
  • Muscle Atrophy
  • Age-Related Sarcopenia
  • Rapamune (sirolimus) 1Mg Tablet
  • Unilateral resistance exercise training
  • Derby, United Kingdom
    University of Nottingham School of Medicine
Jun 7, 2022

Vitiligo Trial in Charleston (Rapamycin, Placebo)

Recruiting
  • Vitiligo
  • Charleston, South Carolina
    Medical University of South Carolina
Aug 2, 2022

Brainstem Cavernous Malformations Trial in Shanghai (Sirolimus)

Not yet recruiting
  • Brainstem Cavernous Malformations
  • Shanghai, Shanghai, China
    Huashan Hospital, Fudan University
Oct 13, 2023

Renal Failure Trial in Columbus (Everolimus, Sirolimus)

Completed
Has Results
  • Renal Failure
  • Columbus, Ohio
    The Ohio State University Wexner Medical Center
Nov 2, 2021

PTEN Gene Mutation, PTEN Hamartoma Tumor Syndrome, PTEN Hamartoma Syndrome Trial in Stanford, Boston, Cleveland (Sirolimus,

Not yet recruiting
  • PTEN Gene Mutation
  • +2 more
  • Stanford, California
  • +2 more
Oct 5, 2023

Anemia, Sickle Cell Trial in New York (Siplizumab, Exchange Transfusion, Total Body Irradiation)

Recruiting
  • Anemia, Sickle Cell
  • New York, New York
    Columbia University Irving Medical Center
Oct 9, 2023

Cognitive Impairment, Mild, Alzheimer Trial in San Antonio (Rapamune)

Active, not recruiting
  • Cognitive Impairment, Mild
  • Alzheimer Disease
  • Rapamune
  • San Antonio, Texas
    UTHSA McDermott Clinical Sciences Building
Feb 3, 2022

Cutaneous Squamous Cell Carcinoma, Advanced Cancer Trial in Boston (Cemiplimab, Everolimus, Sirolimus)

Recruiting
  • Cutaneous Squamous Cell Carcinoma
  • Advanced Cancer
  • Boston, Massachusetts
    Dana Farber Cancer Institute
Jan 19, 2023

Arteriovenous Malformations Trial in Belgium, France (Sirolimus)

Recruiting
  • Arteriovenous Malformations
  • Bruxelles, Belgium
  • +12 more
Aug 23, 2021

Sickle Cell Anemia Trial run by the NHLBI (PBSC Transplant, Alemtuzumab, Sirolimus)

Active, not recruiting
Has Results
  • Sickle Cell Anemia
  • PBSC Transplant
  • +4 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Oct 13, 2022

Pulmonary Fibrosis, COVID-19 Pneumonia, Long COVID Trial in Chicago (Sirolimus)

Recruiting
  • Pulmonary Fibrosis
  • +2 more
  • Chicago, Illinois
    University of Chicago
Nov 18, 2022

Castleman Disease, Castleman's Disease, Multicentric Trial in Little Rock, La Jolla, Philadelphia (Sirolimus)

Recruiting
  • Castleman Disease
  • Castleman's Disease, Multicentric
  • Little Rock, Arkansas
  • +3 more
Jan 6, 2023

Heart Failure Trial in Rochester (Rapamune)

Recruiting
  • Heart Failure
  • Rapamune
  • Rochester, Minnesota
    Mayo Clinic Rochester
Jun 28, 2022

Hemangioendothelioma Trial in Chengdu (Sirolimus)

Recruiting
  • Hemangioendothelioma
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
May 1, 2022

Thyroid-Associated Ophthalmopathy Trial (Sirolimus 1 mg Oral Tablet, Methylprednisolone)

Not yet recruiting
  • Thyroid-Associated Ophthalmopathy
  • (no location specified)
Mar 18, 2022

Severe Aplastic Anemia Trial run by the NHLBI (ATG+Rapamune+cyclosporine, ATG+cyclosporine)

Completed
  • Severe Aplastic Anemia
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Jun 29, 2021

Kaposiform Hemangioendothelioma Trial in Chengdu (Sirolimus)

Recruiting
  • Kaposiform Hemangioendothelioma
  • Chengdu, Sichuan, China
    West China Hospital of Sichuan University
Apr 6, 2022

Kidney Transplant, Delayed Graft Function Trial in Baltimore (Tacrolimus, Sirolimus)

Terminated
Has Results
  • Kidney Transplant
  • Delayed Graft Function
  • Baltimore, Maryland
    University of Maryland Medical Center
Mar 29, 2022

Graft Vs Host Disease, GVHD Trial in Tampa, Minneapolis (Pacritinib, Sirolimus, Tacrolimus)

Active, not recruiting
  • Graft Vs Host Disease
  • GVHD
  • Tampa, Florida
  • +1 more
Jul 27, 2022

Ovarian Serous Tumor, Recurrent Ovarian Carcinoma Trial in Rochester (Auranofin, Laboratory Biomarker Analysis, Sirolimus)

Active, not recruiting
Has Results
  • Ovarian Serous Tumor
  • Recurrent Ovarian Carcinoma
  • Rochester, Minnesota
    Mayo Clinic
Mar 22, 2022

Angiofibroma of Face, Tuberous Sclerosis Trial in China, United States (Sirolimus 0.2%, Sirolimus 0.4%, Placebo ointment)

Recruiting
  • Angiofibroma of Face
  • Tuberous Sclerosis
  • Sirolimus 0.2%
  • +2 more
  • Phoenix, Arizona
  • +7 more
Feb 2, 2022

Multiple Myeloma, Refractory Multiple Myeloma Trial (procedure, drug, radiation)

Withdrawn
  • Multiple Myeloma
  • Refractory Multiple Myeloma
  • nonmyeloablative allogeneic hematopoietic stem cell transplantation
  • +7 more
  • (no location specified)
Jan 4, 2023

Liver Disease Trial in Groningen, Leiden, Rotterdam (Tacrolimus and Sirolimus, Tacrolimus)

Completed
  • Liver Disease
  • Groningen, Netherlands
  • +2 more
Mar 17, 2022

Sickle Cell Disease Trial in Chicago (Allogeneic Non-Myeloablative Stem Cell Transplantation, Alemtuzumab, Sirolimus)

Recruiting
  • Sickle Cell Disease
  • Allogeneic Non-Myeloablative Stem Cell Transplantation
  • +2 more
  • Chicago, Illinois
    University of Illinois at Chicago
Feb 16, 2022